FDA Inspection 1192736 — Wyeth Pharmaceutical Division of Wyeth Holdings LLC

Wyeth Pharmaceutical Division of Wyeth Holdings LLC — FEI 1000110954

The FDA completed an inspection of Wyeth Pharmaceutical Division of Wyeth Holdings LLC on November 18, 2022 in Sanford, NC. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Biologics.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
November 18, 2022
Fiscal Year
2023
Product Type
Biologics
Project Area
Vaccines and Allergenic Products
Location
Sanford, NC (United States)